Nephros Inc. (NEPH) is a publicly traded Healthcare sector company. As of August 25, 2026, NEPH trades at $4.20 with a market cap of $44.31M and a P/E ratio of 38.18. NEPH moved +2.94% today. Year to date, NEPH is -16.39%; over the trailing twelve months it is +1.49%. Its 52-week range spans $1.39 to $6.42. Analyst consensus is buy with an average price target of $6.38. Rallies surfaces NEPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nephros Inc. (NEPH) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NEPH moved +2.94% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $4.20 |
| Market Cap | $44.31M |
| P/E Ratio | 38.18 |
| EPS | $0.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.42 |
| 52-Week Low | $1.39 |
| Volume | 70 |
| Avg Volume | 0 |
| Revenue (TTM) | $18.79M |
| Net Income | $1.19M |
| Gross Margin | 61.87% |
2 analysts cover NEPH: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.38.